1. Home
  2. RDW vs EVO Comparison

RDW vs EVO Comparison

Compare RDW & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDW
  • EVO
  • Stock Information
  • Founded
  • RDW 2020
  • EVO 1993
  • Country
  • RDW United States
  • EVO Germany
  • Employees
  • RDW N/A
  • EVO N/A
  • Industry
  • RDW Military/Government/Technical
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • RDW Industrials
  • EVO Health Care
  • Exchange
  • RDW Nasdaq
  • EVO Nasdaq
  • Market Cap
  • RDW 1.5B
  • EVO 1.4B
  • IPO Year
  • RDW N/A
  • EVO 2021
  • Fundamental
  • Price
  • RDW $15.87
  • EVO $3.76
  • Analyst Decision
  • RDW Strong Buy
  • EVO Buy
  • Analyst Count
  • RDW 6
  • EVO 2
  • Target Price
  • RDW $17.71
  • EVO $5.90
  • AVG Volume (30 Days)
  • RDW 3.7M
  • EVO 159.9K
  • Earning Date
  • RDW 08-06-2025
  • EVO 08-13-2025
  • Dividend Yield
  • RDW N/A
  • EVO N/A
  • EPS Growth
  • RDW N/A
  • EVO N/A
  • EPS
  • RDW N/A
  • EVO N/A
  • Revenue
  • RDW $277,704,000.00
  • EVO $851,944,444.00
  • Revenue This Year
  • RDW $44.20
  • EVO $10.08
  • Revenue Next Year
  • RDW $46.78
  • EVO $10.99
  • P/E Ratio
  • RDW N/A
  • EVO N/A
  • Revenue Growth
  • RDW 1.36
  • EVO 1.50
  • 52 Week Low
  • RDW $4.87
  • EVO $2.84
  • 52 Week High
  • RDW $26.66
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • RDW 49.81
  • EVO 41.37
  • Support Level
  • RDW $16.12
  • EVO $4.06
  • Resistance Level
  • RDW $20.57
  • EVO $4.44
  • Average True Range (ATR)
  • RDW 1.76
  • EVO 0.11
  • MACD
  • RDW -0.31
  • EVO -0.04
  • Stochastic Oscillator
  • RDW 27.58
  • EVO 0.00

About RDW Redwire Corporation

Redwire Corp is engaged in mission-critical space solutions and reliable components for the next-generation space economy. It assists its customers in solving the complex challenges of future space missions and industries. The company's space infrastructure offerings include a broad array of modern products and services, which have been enabling space missions. The company's Heritage plus Innovation strategy enables it to combine decades of flight heritage with a culture creating new technologies that are the building blocks of space infrastructure for government and commercial customers.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: